日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Executive Summary of the Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease-2025 Update

亚太肾脏病学会糖尿病肾病临床实践指南(2025年更新版)执行摘要

Liew, Adrian; Bavanandan, Sunita; Hao, Chuan-Ming; Lim, Soo Kun; Prasad, Narayan; Sahay, Manisha; Susantitaphong, Paweena; Roberts, Veena; Wijewickrama, Eranga; Wong, Muh Geot; Tang, Sydney C W

Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease-2025 Update

亚太肾脏病学会糖尿病肾病临床实践指南-2025更新版

Liew, Adrian; Bavanandan, Sunita; Hao, Chuan-Ming; Lim, Soo Kun; Prasad, Narayan; Sahay, Manisha; Susantitaphong, Paweena; Roberts, Veena; Wijewickrama, Eranga; Wong, Muh Geot; Tang, Sydney C W

Case report: BTK inhibitors is effective in type II mixed cryoglobulinemia with wild-type MyD88

病例报告:BTK抑制剂对伴有野生型MyD88的II型混合型冷球蛋白血症有效

Xu, Mingyue; Xu, Yunyu; Yuan, Li; Shang, Da; Chen, Ruiying; Liu, Shaojun; Li, Yan; Liu, Aiping; Liu, Ruilai; Wang, Qian; Ding, Tianling; Xie, Qionghong; Hao, Chuan-Ming

Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic

奥妥珠单抗治疗膜性肾病:COVID-19 大流行期间的疗效和安全性问题

Xu, Mingyue; Chen, Ruiying; Wang, Yifeng; Huang, Xiaoyun; Zhang, Hanzhen; Zhao, Wenqian; Zhang, Min; Xu, Yunyu; Liu, Shaojun; Hao, Chuan-Ming; Xie, Qionghong

Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in China

中国单中心研究:11年间经活检证实的肾脏疾病谱的变化

Wang, Yujia; Zhang, Liyin; Yuan, Li; Xie, Qionghong; Liu, Shaojun; Hao, Chuan-Ming

Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions

对于伴有局灶节段性肾小球硬化病变的特发性膜性肾病,可能需要积极治疗。

Cheng, Ping; Xie, Qionghong; Liu, Shaojun; Liu, Xiaobin; Wang, Liang; Hao, Chuan-Ming

Genome-Wide Association Study in Acute Tubulointerstitial Nephritis

急性肾小管间质性肾炎的全基因组关联研究

Zhou, Xu-Jie; Su, Tao; Xie, Jingyuan; Xie, Qiong-Hong; Wang, Li-Zhong; Hu, Yong; Chen, Gang; Jia, Yan; Huang, Jun-Wen; Li, Gui; Liu, Yang; Yu, Xiao-Juan; Nath, Swapan K; Tsoi, Lam C; Patrick, Matthew T; Berthier, Celine C; Liu, Gang; Wang, Su-Xia; Xu, Huji; Chen, Nan; Hao, Chuan-Ming; Zhang, Hong; Yang, Li

Rituximab as Initial Therapy in Adult Patients With Minimal Change Disease

利妥昔单抗作为成人微小病变性关节炎患者的初始治疗

Guan, Nan; Zhang, Min; Zhang, Min; Chen, Ruiying; Xie, Qionghong; Hao, Chuan-Ming

The metabolites of de novo NAD(+) synthesis are a valuable predictor of acute kidney injury

从头合成 NAD(+) 的代谢产物是急性肾损伤的重要预测指标。

Wang, Yujia; Guan, Yi; Xie, Qionghong; Gong, Weiyuan; Li, Jianhua; Chen, Tong; Xu, Yanfang; Xu, Ning; Chen, Shaohao; Chen, Mo; Wang, Zhengxin; Hao, Chuan-Ming

Updates on Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in the Treatment of Renal Anemia

缺氧诱导因子脯氨酰羟化酶抑制剂在肾性贫血治疗中的最新进展

Li, Jing; Haase, Volker H; Hao, Chuan-Ming